The company had previously forecast annual revenue growth between 5% and 6% and earnings per share range of 2.20 to 2.40 euros for 2026 , News.az reports, citing Reuters. *** The German medical technology company also revised its outlook for earnings per share downwards to 2.20-2.30 euros.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Siemens Healthineers suffered a decline in revenue in the first quarter, apparently due to ongoing problems: The board is lowering its targets for the full year.
Persistent problems of the laboratory diagnostics division as well as the rising inflation make the medical technology group more pessimistic for the current financial year.